Cannabis News

Giving growers confidence that their substrate partner is always ready

Published

3 months ago

December 2, 2025

admin

As the demand for organic grow media is growing rapidly worldwide, CoirMedia is increasing its manufacturing capacity with a new factory dedicated to the production of high quality grow bags. CoirMedia has opened a new manufacturing plant to manufacture grow bags to meet the growing demand for CoirMedia substrates from growers around the world. “The plant has the capacity to produce three containers of grow bags daily, providing consistent and assured supply to global markets anytime, anywhere,” says CoirMedia’s Abhishek Pravin.

Capacity to produce raw materials
He explained that the demand for quality CoirMedia substrates has grown dramatically in recent years as producers switch to CoirMedia substrates. “We have established a strong reputation for reliability, technical accuracy and customer-oriented service.” The organization has the capacity to produce large volumes of raw materials in Sri Lanka to ensure total control over quality and continuity of supply from registered farmers. “The new factory supports this attitude by using increased capacity combined with strict quality control, enabling us to ensure that growers anywhere in the world are able to provide CoirMedia with what they need.”

Consistent delivery
The factory is part of CoirMedia’s wider strategy to enhance its global supply chain network, ensuring consistent delivery to key horticultural hubs in Europe, the Americas and Asia-Pacific. All processes in the new factory are under CoirMedia’s certified quality system, ensuring traceability and compliance with international substrate standards.

“In addition to improving efficiency, the facility adheres to environmentally friendly practices, incorporating renewable resources of coir and minimizing all waste in production. Green production methods help reduce our carbon footprint and ensure our dedication to environmentally friendly cultivation from material sourcing to delivery,” continues Abhishek. “The plant is set up with specific production lines of grow bags for each specific crop. A proprietary chip formulation established and perfected over several seasons by international experts is applied to ensure uniformity and consistency of performance. Each grow bag is double cleaned and treated with calcium for a stable EC and pH balance, providing growers with a clean and reliable substrate for their crops.”

Healthy root development
The new arrangement emphasizes capacity and quality improvement. Regulated processes ensure consistent texture, cleanliness and drainage performance from batch to batch. Attention is paid to air-filled porosity, water-holding capacity, and coir uniformity, EC, and pH to ensure that grow bags allow firm, healthy root development throughout the life of the crop.

CoirMedia also offers custom blends to suit various crop needs, regional conditions and grower preferences. The R&D team continues to update the formulas based on ongoing feedback from major growers and partners to keep the product current with developing new growing practices and crop genetics.

“Our unique chip formulation has been tested across seasons and continents. With this new facility, our team is ready to meet grower demand anytime, anywhere. This isn’t just about more production; it’s about giving farmers the confidence that their substrate partner is always ready,” says Abhishek.

To support production, CoirMedia has also established a specialized logistics unit to provide convenient and timely delivery anytime, anywhere. “With guaranteed shipping lines and stable supply arrangements, farmers can have safe and timely delivery to their homes without delays. Farmers deserve not only a product, but also peace of mind. Our logistics systems ensure convenient and timely supply wherever our customers are.”

For more information:
Choir Media
Abhishek Pravin
(email protected)
www.Coirmedia.co.uk

Related Topics:confidence Giving growers partner ready substrate

Up Next

Marijuana Business Owner Running For Congress Says Federal Legalization Is The ‘Only Path’ For ‘National Market Stability’

Don't Miss

San Marino MMJ grower hits perpetual cycle, gets ready to hit EU market

Cannabis News

Cannabis products recalled due to “unreliable” tests

Published

17 hours ago

March 3, 2026

admin

New York State’s Office of Cannabis Management (OCM) has recalled several cannabis products after finding that reported results from a testing laboratory were “unreliable.”

OCM says it has found a total of 54 product lots that tested false positive for Aspergillus, the mold that causes disease. According to OCM, another batch of product had incorrect results for the heavy metal cadmium.

“When test results are inaccurate or unclear, product safety and, in turn, the safety of New York State consumers cannot be guaranteed,” said OCM Executive Deputy Director of Licensing, Enforcement and Laboratories Stephen Geskey. “It’s not a risk OCM is willing to take.”

This information comes from an audit of inspections and records conducted by Keystone State Testing New York between December 2025 and January 2026. According to OCM, there have been no reports of the effects of consuming any of the products.

Cannabis News

Virginia House And Senate Lawmakers Advance Marijuana Sales Legalization Bills Toward Governor’s Desk

Published

17 hours ago

March 3, 2026

admin

The march to legalize the sale of recreational marijuana in Virginia continues, with the full House of Representatives and a Senate committee advancing a pair of bills to create a regulated adult cannabis market in the commonwealth.

The House on Tuesday approved the second reading of the cannabis sale bill passed by the Senate, giving it the chance to pass it definitively in the chamber. Earlier, a House measure moved through the Senate Finance and Appropriations Committee on a 10-5 vote, sending the measure back to the floor for consideration.

Both chambers’ marijuana-sale proposals aim to give adults a legal way to buy cannabis, legalizing both state possession and home cultivation in 2021, though there are key differences between them.

Bicameral measures—HB 642 and SB 542—Recently changed to allow micro business licensees to cultivate, process or conduct retail sales at two locations instead of one, as long as they are within 10 miles of each other and operate under common ownership and control.

Lawmakers also revised the legislation to clarify that current medical cannabis businesses would only be able to grow cannabis indoors, including in secure greenhouses with a total hood of 70,000 square feet. The amendments also would not allow additional marijuana licenses with “dual-use privileges” beyond medical licenses.

Finally, the measure’s conversion fee structure was revised to pay current medical marijuana companies the privilege of dividing the adult-use market into three parts.

There are some key differences between the House bills that still need to be ironed out — related to the start date of legal sales and cannabis tax rates — before a final product can be delivered to the governor’s desk.

Here are the key details of Virginia’s marijuana sales legalization legislation, SB 542 and HB 642:

Adults would be able to purchase up to 2.5 ounces of marijuana in a single transaction, or up to an equivalent amount of other cannabis products, as determined by regulators.
The House bill sets a statewide sales date of Nov. 1, 2026, while the Senate measure would allow it to begin on Jan. 1, 2027.
The Senate bill would impose a 12.875 percent excise tax on cannabis products, in addition to a 1.125 percent state sales tax and a mandatory 3 percent local tax. The House measure would apply a 6 percent excise tax, as well as a 5.3 percent retail sales and use tax, allowing municipalities to impose a 3.5 percent local tax.
Under the House bill, the Virginia Cannabis Control Authority would oversee licensing and regulation of the new industry, while the Senate legislation calls for a new combined Alcoholic Beverage and Cannabis Control Authority.
The House bill calls for the proceeds to be allocated to a new Cannabis Equity Reinvestment Fund (60 percent), early childhood education (10 percent), the Department of Behavioral and Developmental Health Services (25 percent) and public health initiatives (5 percent). The Senate proposal, on the other hand, would put 30 percent into the capital reinvestment fund, 40 percent for early childhood education, 25 percent for the department of behavioral and developmental health services and 5 percent for public health initiatives.
Local governments could not allow marijuana companies to operate in their area.
Delivery services would be allowed.
Serving sizes would be limited to 10 milligrams of THC, with no more than 100 mg of THC per package.
Existing medical cannabis operators could enter the adult-use market if they pay a license conversion fee set at $15 million in the Senate bill and $10 million in the House measure.
Cannabis businesses should implement peaceful labor agreements with their employees.
A legislative committee would direct the addition of local consumer licenses and micro-enterprise cannabis event permits that would allow licensees to hold sales at farmers markets or pop-up locations. The Virginia Alcoholic Beverage Control Authority would also investigate the possibility of involvement in marijuana regulation and enforcement.

Both the Virginia House and Senate Last month, he took action on multiple marijuana bills during a major deadline—accept proposals to legalize the sale of cannabis, provide a way to punish previous marijuana convictions and allow access to medical cannabis for seriously ill patients in hospitals.

As for the Senate marijuana sales bill, members recently clashed in committee over amendments to the body version that would add new penalties for illegal cannabis activity.

The amendments in the Judiciary Committee’s case included penalties for consumers who purchase from unlicensed sources, recriminalizing possession and sale of cannabis by those under 21, making it a Class 1 felony for a first offense and a felony punishable by a mandatory prison sentence for a second offense. As revised, the bill would also increase the penalty for unlicensed cultivation to a felony with up to five years in prison and make it a felony to transport cannabis with the intent to distribute it across state lines.

But the Finance and Appropriations Committee backed down the amendments last month, sending a letter to senators under pressure from a coalition of advocacy groups. saying that they undermined the “intent” of the legislation and “the will of the people” by adding criminal penalties to certain cannabis-related activities.

In general, both chambers’ commercial sales bills have largely aligned with recommendations released by the legislature in December. Joint Committee to Oversee the Transition to the Commonwealth Retail Cannabis Market.

Meanwhile, some members of the GOP have aligned ideologically with their Democratic colleagues throughout this legislative process, breaking with the majority of their caucus. in favor of creating a regulated market for adults to buy cannabis.

Since legalizing cannabis ownership and home cultivation in 2021, Virginia lawmakers have been working to establish a commercial marijuana market– Only for those efforts to stall under former Gov. Glenn Youngkin (R), who twice vetoed measures sent to his desk by the Legislature.

Governor Abigail Spanberger (D), for her part, supports legalizing the sale of marijuana to adults..

Meanwhile, members of the Virginia House and Senate advanced a pair of bills Monday, with amendments that provide a pathway to resentencing for people with prior marijuana convictions.

Members of the Senate and House Judiciary Committees approved alternate versions of the opposite chamber’s reform bill on Monday, setting the stage for bicameral negotiations as the measures move through the legislative process.

Legislation introduced in both chambers would create a process to consider changing the sentences under which people incarcerated or on community custody for certain felonies involving the possession, manufacture, sale or distribution of marijuana could receive an automatic trial.

Separately last month, the Virginia House patients passed a bill to allow the use of medical marijuana in hospitals. It would require health care facilities to implement policies “to address the situation in which an eligible patient is authorized to use medical cannabis.”

The Senate passed various pieces of legislation use of medical cannabis in healthcare facilities last month

—
It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.

Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—

Meanwhile, the Virginia House passed the bill earlier this month Protecting the rights of parents who use marijuana by complying with state laws.

Del. According to the proposal by Nadarius Clark (D), a parent or guardian’s own use of cannabis “shall not serve as a basis for a finding of abuse or neglect of a child unless other facts establish that its possession or consumption causes or produces physical or mental injury to the child.”

“A person’s legal possession or consumption of substances permitted (under state marijuana law) shall not serve as a basis for limiting custody or visitation unless other facts establish that such possession or consumption is not in the best interest of the child,” reads the text of HB 942.

Separately, the Virginia Department of Labor and Industry has published a new defining workplace protections for cannabis users.

Photo by Chris Wallis // Side Pocket Images.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Cannabis News

Swiss company launches nationwide price comparison tool for cannabis

Published

2 days ago

March 2, 2026

admin

Evidena Care AG is one of the leading Swiss telemedicine platforms and specialized medical practices for medical cannabis. The company currently supports more than 2,000 patients across the country. Under the direction of Dr. Nicolai Berardi and two other specialist doctors, Evidena Care has focused on evidence-based, responsible and patient-centered treatment for the past two years.

Now, Evidena Care is launching a nationwide online comparison portal for medical cannabis products. The platform is designed for patients who already have a valid medical prescription and want a clear and reliable view of the market. For the first time in Switzerland, patients can directly compare products and prices from the country’s largest pharmacies in one place.

Medical cannabis plays an essential role in the treatment plans of many patients. At the same time, prices can vary significantly between pharmacies, even when the products contain the same levels of active ingredients. As these costs are often not covered by health insurance, or only partially covered, many patients have a heavy financial burden. The new portal addresses this issue by bringing transparency to a market that until now has been difficult to navigate.

The platform provides an overview of available products and dosages, clearly lists the active ingredient content, such as THC and CBD levels, and displays the current prices of leading Swiss pharmacies. Patients can directly compare options and make informed decisions that help optimize their therapy costs, without compromising medical guidance.

“Patients should not be victims of non-transparent pricing structures,” says Dr. Nicolai Berardi, CEO of Evidena Care AG. “We are creating transparency with our comparison portal, strengthening the self-responsibility of those affected and promoting fair competition in the interests of patients.”

The portal is only for people with a valid prescription. It serves as a true information tool and supports cost optimization in an existing therapy supervised by a physician.

For more information:
Evidena Care AG
Email: (email protected)
https://evidena.care/